134 related articles for article (PubMed ID: 25553241)
1. Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells.
Kuo CC; Chen JJ; Tsai JY; Hsueh CT
Biomark Res; 2014; 2(1):26. PubMed ID: 25553241
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Chinese herbal medicine usage and its effect on survival of lung cancer patients in Taiwan.
Li TM; Yu YH; Tsai FJ; Cheng CF; Wu YC; Ho TJ; Liu X; Tsang H; Lin TH; Liao CC; Huang SM; Li JP; Lin JC; Lin CC; Liang WM; Lin YJ
J Ethnopharmacol; 2018 Mar; 213():92-100. PubMed ID: 29100936
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
4. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest.
Kao ST; Yeh CC; Hsieh CC; Yang MD; Lee MR; Liu HS; Lin JG
Life Sci; 2001 Aug; 69(13):1485-96. PubMed ID: 11554610
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Schwartz GK; Haimovitz-Friedman A; Dhupar SK; Ehleiter D; Maslak P; Lai L; Loganzo F; Kelsen DP; Fuks Z; Albino AP
J Natl Cancer Inst; 1995 Sep; 87(18):1394-9. PubMed ID: 7658500
[TBL] [Abstract][Full Text] [Related]
6. In vivo metabolic profiles of Bu-Zhong-Yi-Qi-Tang, a famous traditional Chinese medicine prescription, in rats by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
Hu L; Yao Z; Qin Z; Liu L; Song X; Dai Y; Kiyohara H; Yamada H; Yao X
J Pharm Biomed Anal; 2019 Jul; 171():81-98. PubMed ID: 30981193
[TBL] [Abstract][Full Text] [Related]
7. Integrating network pharmacology and experimental verification to decipher the immunomodulatory effect of Bu-Zhong-Yi-Qi-Tang against poly (I:C)-induced pulmonary inflammation.
Hu L; Yamamoto M; Chen J; Duan H; Du J; He L; Shi D; Yao X; Nagai T; Kiyohara H; Yao Z
Front Pharmacol; 2022; 13():1015486. PubMed ID: 36304166
[TBL] [Abstract][Full Text] [Related]
8. Immune-modulatory effects of bu-zhong-yi-qi-tang in ovalbumin-induced murine model of allergic asthma.
Yang SH; Kao TI; Chiang BL; Chen HY; Chen KH; Chen JL
PLoS One; 2015; 10(6):e0127636. PubMed ID: 26035827
[TBL] [Abstract][Full Text] [Related]
9. Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records.
Lyu S; Zhang CS; Mao Z; Guo X; Li Z; Luo X; Sun J; Su Q
Front Aging Neurosci; 2024; 16():1362948. PubMed ID: 38756536
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-alpha production by peripheral blood mononuclear cells.
Kao ST; Yang SL; Hsieh CC; Yang MD; Wang TF; Lin JG
Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):711-20. PubMed ID: 11105783
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac.
Ma L; Xie YL; Yu Y; Zhang QN
World J Gastroenterol; 2005 Mar; 11(12):1829-32. PubMed ID: 15793875
[TBL] [Abstract][Full Text] [Related]
12. The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine.
Kim SH; Lee SE; Oh H; Kim SR; Yee ST; Yu YB; Byun MW; Jo SK
Am J Chin Med; 2002; 30(1):127-37. PubMed ID: 12067087
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics.
Zheng XF; Tian JS; Liu P; Xing J; Qin XM
J Ethnopharmacol; 2014 Feb; 151(2):912-20. PubMed ID: 24333365
[TBL] [Abstract][Full Text] [Related]
14. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
[TBL] [Abstract][Full Text] [Related]
15. Effects of Bu-Zhong-Yi-Qi-Tang for the treatment of functional dyspepsia: a feasibility study protocol.
Kim J; Kim H; Kim KH
Integr Med Res; 2017 Sep; 6(3):317-324. PubMed ID: 28951846
[TBL] [Abstract][Full Text] [Related]
16. Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress.
Matsunaga T; Tsuji Y; Kaai K; Kohno S; Hirayama R; Alpers DH; Komoda T; Hara A
Cancer Chemother Pharmacol; 2010 Aug; 66(3):517-26. PubMed ID: 19967538
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.
Hsueh CT; Chiu CF; Kelsen DP; Schwartz GK
Cancer Chemother Pharmacol; 2000; 45(5):389-96. PubMed ID: 10803922
[TBL] [Abstract][Full Text] [Related]
18. Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.
Zheng LD; Tong QS; Wang L; Liu J; Qian W
World J Gastroenterol; 2005 Jan; 11(1):79-83. PubMed ID: 15609401
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
Perry RR; Greaves BR; Rasberry U; Barranco SC
Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells.
Ko JC; Chen JC; Wang TJ; Zheng HY; Chen WC; Chang PY; Lin YW
Biochem Pharmacol; 2016 Apr; 105():91-100. PubMed ID: 26921637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
